PNC Financial Services Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
31,879
+5,741
+22% +$170K ﹤0.01% 1325
2026
Q1
$724K Buy
26,138
+12,672
+94% +$326K ﹤0.01% 1456
2025
Q4
$292K Buy
13,466
+1,121
+9% +$22.1K ﹤0.01% 2030
2025
Q3
$187K Sell
12,345
-1,589
-11% -$19.7K ﹤0.01% 2351
2025
Q2
$157K Buy
13,934
+3,686
+36% +$40K ﹤0.01% 2377
2025
Q1
$103K Buy
10,248
+3,169
+45% +$34.3K ﹤0.01% 2640
2024
Q4
$83.7K Buy
7,079
+1,507
+27% +$17.8K ﹤0.01% 2792
2024
Q3
$64.3K Sell
5,572
-127
-2% -$1.45K ﹤0.01% 2942
2024
Q2
$60.2K Buy
5,699
+4,454
+358% +$48.8K ﹤0.01% 2928
2024
Q1
$13.1K Buy
1,245
+648
+109% +$6.99K ﹤0.01% 3643
2023
Q4
$6.7K Buy
597
+312
+109% +$3.04K ﹤0.01% 3860
2023
Q3
$3.33K Buy
+285
New +$3.22K ﹤0.01% 4099

Other funds holding ROIV

PNC Financial Services Group's ROIV Position: Q2 2026 in Review

PNC Financial Services Group increased its Roivant Sciences (ROIV) stake by 22% in Q2 2026, buying an estimated $170K and bringing the position to 31,879 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

PNC Financial Services Group first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • PNC Financial Services Group held 31,879 shares of Roivant Sciences worth $1.13M as of Q2 2026.
  • PNC Financial Services Group bought 5,741 Roivant Sciences shares in Q2 2026, an estimated $170K.
  • Roivant Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1325 holding.
  • PNC Financial Services Group first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.